To view the PDF file, sign up for a MySharenet subscription.

ASCENDIS HEALTH LIMITED - Report on Fifth Annual General Meeting Proceedings

Release Date: 10/11/2017 12:20
Code(s): ASC     PDF:  
Wrap Text
Report on Fifth Annual General Meeting Proceedings

Ascendis Health Limited
(Registration number 2008/005856/06)
(Incorporated in the Republic of South Africa)
JSE share code: ASC
ISIN: ZAE000185005
(“Ascendis of “the Company”)

Report on Fifth Annual General Meeting Proceedings

Ascendis shareholders are advised that at the Fifth Annual General Meeting of members held on Thursday,
9th November 2017, all the ordinary and special resolutions as proposed in the Notice of the Annual
General Meeting were approved by the requisite majority of members. In this regard, Ascendis confirms
the voting results from the Fifth Annual General Meeting as follows:

                                                                             %          Number
Total number of shares that could be voted at meeting                        100%       435,939,348
Total number of shares present/represented including proxies at meeting      79.66%     347,260,651
Total number of members present/presented by representation                             59

                                                 Votes in       Votes        Abstain      Shares
                                                 Favour         Against                   voted

Ordinary Resolution Number 1                     328,937,053    5,000        18,318,598   328,942,053
Adoption of Annual Financial Statements          100.00%        0.00%        4.20%        75.46%

Ordinary Resolution Number 2                     328,936,818    5,065        18,318,768   328,941,883
Re-appointment of auditors                       100.00%        0.00%        4.20%        75.46%

Ordinary Resolution Number 3.1                   328,929,030    10,723       18,320,898   328,939,753
Re-election of John Andrew Bester as an          100.00%        0.00%        4.20%        75.46%
independent non-executive director               

Ordinary Resolution Number 3.2                   327,078,707    1,861,046    18,320,898   328,939,753
Re-election of Gary John Shayne as a non-        99.43%         0.57%        4.20%        75.46%
executive director                               

Ordinary Resolution Number 4.1                   328,929,032    10,721       18,320,898   328,939,753
Appointment of Bharti Harie as a member of       100.00%        0.00%        4.20%        75.46%
the Audit committee                              

Ordinary Resolution Number 4.2                   321,249,054    7,687,934    18,323,663   328,936,988
Appointment of John Andrew Bester as a           97.66%         2.34%        4.20%        75.45%
member of the Audit committee                    

Ordinary Resolution Number 4.3                   326,990,949    1,946,039    18,323,663   328,936,988
Appointment of Dr Kinesh Sachidanandan           99.41%         0.59%        4.20%        75.45%
Pather as a member of the Audit committee        

Ordinary Resolution Number 5                     290,238,134    37,430,627   19,591,890   327,668,761
General authority to issue shares of the         88.58%         11.42%       4.49%        75.16%  
Company                                         

Ordinary Resolution Number 6                     281,346,434    46,322,327   19,591,890   327,668,761
General authority to issue shares of the         85.86%         14.14%       4.49%        75.16%
Company for cash                                 

                                                 Votes in       Votes        Abstain      Shares
                                                 Favour         Against                   voted

Special Resolution Number 1                      327,111,134    1,826,239    18,323,278   328,937,373
Approval of independent non-executive            99.44%         0.56%        4.20%        75.45%
directors’ remuneration                          

Special Resolution Number 2                      291,374,428    37,563,006   18,323,217   328,937,434
General authority to repurchase shares in the    88.58%         11.42%       4.20%        75.45% 
Company                                          

Special Resolution Number 3                      281,453,945    47,477,758   18,328,948   328,931,703
Approval of financial assistance in terms of     85.57%         14.43%       4.20%        75.45% 
section 44 of the Companies Act                  

Special Resolution Number 4                      277,454,732    51,476,971   18,328,948   328,931,703
Approval of financial assistance in terms of     84.35%         15.65%       4.20%        75.45%
section 45 of the Companies Act                  

Special Resolution Number 5                      328,933,259    5,896        18,321,496   328,939,155
Amendment to the Company’s Memorandum            100.00%        0.00%        4.20%        75.46%
of Incorporation to discontinue using dividend
cheques as a distribution to shareholders        

Ordinary Resolution Number 7                     294,796,669    34,128,617   18,335,365   328,925,286
Endorsement of Ascendis’ Remuneration            89.62%         10.38%       4.21%        75.45%
Policy                                           

Ordinary Resolution Number 8                     328,940,944    1,109        18,318,598   328,942,053
Authority to sign all documents                  100.00%        0.00%        4.20%        75.46%

Votes withheld are not votes in law and have not been counted in the calculation of the proportion of
votes 'for' or 'against' a resolution. Proxy appointments which gave discretion to the Chairman have
been included in the 'for' total.

Andy Sims
Company Secretary
Ascendis Health Limited

10 November 2017

Sponsor: Investec Bank Limited

Date: 10/11/2017 12:20:00 Produced by the JSE SENS Department. The SENS service is an information dissemination service administered by the JSE Limited ('JSE'). 
The JSE does not, whether expressly, tacitly or implicitly, represent, warrant or in any way guarantee the truth, accuracy or completeness of
 the information published on SENS. The JSE, their officers, employees and agents accept no liability for (or in respect of) any direct, 
indirect, incidental or consequential loss or damage of any kind or nature, howsoever arising, from the use of SENS or the use of, or reliance on,
 information disseminated through SENS.